BKYI Company Profile and Key Details

BIO-key International, Inc. trades at a P/E ratio of -0.72, slightly below the S&P 500 average, with a price-to-sales ratio of 0.74 and a price-to-book ratio of 0.4 suggesting the stock is closer to book value. The P/FCF stands at -1.17, also below market averages.

BIO-key International, Inc. (NASDAQ:BKYI) closed at $4.64 USD, losing -$0.13 (-2.73%) from the previous close of $4.77. The stock is currently mid-range between its 52-week high and low $3.10 and $19.70. With a market capitalization of about $5.04 million, BIO-key International, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.43). Key stats such as the average daily volume over the past year has been around 21.01 thousand shares, volume is running light vs its 52-week average. Headquartered in Holmdel, NJ, BIO-key International, Inc. operates in the Technology sector and the Information Technology Services industry. Led by CEO Michael W. DePasquale, the company employs approximately 42 people and listed since February 21, 1997. BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally.

BIO-key International, Inc. last paid a dividend of 384 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $2.66. This means the shares are trading above this model’s fair value.

Short-term trend indicators are mixed aligned (SMA20 1.47%, SMA50 3.93%, SMA200 -14.9%). The stock’s 14-day RSI is 53.45 (neutral), while the ATR of 0.06 points to moderate volatility. The stock remains hovering near 52-week lows, trading -67.57% below its high and over 25.57% above its low. Average 10-day trading volume of 4.74 thousand shares is below the 3-month average of 17.52 thousand, indicating normal recent market interest.

BIO-key International, Inc. has 1.09 million shares outstanding. The public float is 985.47 thousand shares, elevated short interest at 1.88% of float. This equals 19.64 thousand shares. The short ratio is 0.77 days. Institutional investors hold 8.2% of the float. Insiders own 11.46%. Kwok Fong Wong holds 4.39 million shares, Colatosti Thomas J. has 1.13 million shares and FODERO RANDY has 482.80 thousand shares.

BIO-key International, Inc. generated EPS of -$1.02 over the past year. Five-year average earnings growth is 57.34%. The latest quarter delivered EPS of -$0.15. The next quarter is forecast at $nan. Next year's EPS is expected at $120.69. BIO-key International, Inc. earnings surprise history is a mixed track record. The quarter that ended May 18, 2026, missed forecasts by -75.0%. The prior quarter beat by 171.43%. Over the last six quarters, Apple has recorded several small beats. These include 51.43% in March 27, 2025.

Our AI price prediction model suggests that BIO-key International, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 6.47%, with price expected at $4.94 by August 06, 2026, within a range of $4.54 to $5.38 3-Month Outlook: Projected fall of -70.69%, reaching $1.36 by October 21, 2026, with a range of $0.80 to $1.78. 1-Year Outlook: Projected loss of -53.45%, with price at $2.16 by July 23, 2027, within a range of $0.00 to $0.00.

BIO-key International, Inc. (NASDAQ:BKYI) shares are flat 4.53% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows BIO-key International, Inc. trading at a premium to the broader market with a P/E of -0.72. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $6.00, suggesting 29.31% upside. Our AI forecast model points to short-term strength (6.47% over two weeks), a medium-term fall (-70.69% over three months), and a longer-term loss (-53.45% over one year), with expected trading ranges indicating moderate volatility.